Alcon, Inc. is a global eye care company that develops, manufactures and distributes products for surgical and vision care markets. Its offerings are designed to support eye care professionals, patients and consumers across a broad range of ophthalmic needs.
Alcon’s surgical business provides technologies and products used in cataract, retinal and refractive procedures. These include intraocular lenses, surgical equipment, diagnostic technologies and other instruments and consumables used by ophthalmic surgeons.
The company’s vision care business includes contact lenses, contact lens care products and consumer eye care products, including solutions aimed at addressing dry eye and other common vision-related conditions. Alcon serves customers in markets around the world through a global commercial and manufacturing network.
Alcon traces its origins to 1945, when it was founded in Fort Worth, Texas, as an ophthalmic pharmacy. The company later became part of Nestlé and then Novartis before being separated as an independent, publicly traded company in 2019. Alcon is headquartered in Geneva, Switzerland, and is led by Chief Executive Officer David J. Endicott.
AI Generated. May Contain Errors.
